![](/img/cover-not-exists.png)
85OPrevalence of programmed death ligand-1 (PD-L1) by demographic, disease and sample characteristics in unresectable, stage III NSCLC (PACIFIC)
Planchard, D, Garassino, M C, Paz-Ares, L, Faivre-Finn, C, Spira, A, Gu, Y, Wadsworth, C, Whiteley, J, Scott, M, Boothman, A-M, Ratcliffe, M, Walker, J, Dennis, P A, Antonia, S JVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz067.002
Date:
April, 2019
File:
PDF, 90 KB
2019